DOCSLIB.ORG

Parotid Duct Ligation - 4 Duct Ligation - Bilateral Excision of the Submandibular Glands +/- Ligation of the Parotid Duct Tympanic Neurectomy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Parotid Duct Ligation - 4 Duct Ligation - Bilateral Excision of the Submandibular Glands +/- Ligation of the Parotid Duct Tympanic Neurectomy SialorrheaSialorrhea SalivarySalivary disordersdisorders SialoendoscopySialoendoscopy Sam J Daniel, MD Director Pediatric Otolaryngology Associate Professor Montreal Children’s Hospital McGill University Objectives • Review the rehabilitative, medical, and surgical treatment options for sialorrhea • Discuss novel therapies such as Botox injections in the salivary glands • Discuss the technique and pitfalls of sialoendoscopy • Review selected salivary gland disorders Sialorrhea • Sialorrhea (drooling) is the loss of saliva from the oral cavity • It occurs in healthy children frequently until age 2 Introduction • Neurological disorders in which drooling is problematic: – Parkinson’s disease (close to 80%) – Atypical Parkinsonian syndromes – Amyotrophic lateral sclerosis – Cerebral palsy – Pseudobulbar palsy – Stroke ANATOMYANATOMY && PHYSIOLOGYPHYSIOLOGY ofof thethe salivarysalivary glandsglands Autonomic innervation •Parasympathetic –Abundant, watery saliva –Amylase down •Sympathetic –Scant, viscous saliva –Amylase up Parotid gland Parasympathetic innervation: • Originates in inferior salivary nucleus in medulla. • CN9->sup & inf glossopharyngeal ganglions->tympanic plexus (Jacobson’s nerve) lesser superficial petrosal nerve- >foramen ovale > otic ganglion- synapse with post- ganglionic fibers >auriculotemporal n. • M3 muscarinic receptors of parotid gland Sympathetic innervation: • Postganglionic innervation is provided by the superior cervical ganglion and distributes with the arterial system. Submandibular glands Parasympathetic innervation: • Originates in superior salivary nucleus in pons. • Passes through the nervus intermedius and IAC to join CN7> chorda tympani. The lingual nerve carries presynaptic fibers to the submandibular ganglion. Post- synaptic fibers innervate the submandibular & sublingual glands. M3 muscarinic receptors Sympathetic innervation: • Postganglionic innervation is provided by the superior cervical ganglion and distributes with the arterial system. Saliva Production • Normal saliva production 1- 1.5 liter per day. • Unstimulated salivation- “resting saliva” – 0.5 cc per minute – 70% from submandibular gland, 25% from parotid • Stimulation with a sialogue increases secretions up to 3 to 4 cc per minute. The increase is primarily from the parotid glands (2/3 of secretions). Function of Saliva • Moistens oral mucosa • Digestion (Amylase, • Moistens & cools food Lipase) • Medium for dissolved • Antibacterial food (Lysozyme, IgA, • Buffer (HCO3) Peroxidase, FLOW) • Mineralization • Protective Pellicle Etiology of sialorrhea • Poor oral motor control • Inefficient swallow • Decreased frequency of swallow • Mental delay • Malocclusion or oral structural problem • Mouth-breathing / upper airway obstruction • Postural problem • Medication IMPAIRED OROMOTOR CONTROL IS THE CRUCIAL FACTOR Impact on patient • Physical discomfort • Skin infection • Dehydration • Recurrent pneumonias • Hygiene • Stigmatizing • Rejection • Isolation • Low self-esteem Impact on caregiver • Burden of care: • wiping the child ( mean of 73 times/day) • changing of clothing • soiling of the environment • up to 25 loads of laundry/week (Van Der Burg JJW et al 2006) • Hospitalization of the child • Anxiety and worry for the future • Social isolation Where to start? “Drooling Team” Pediatrician OT PT Dentist Otolaryngologist Neurologist Social worker ApproachApproach toto thethe droolingdrooling patientpatient Evaluation Thomas-Stonell and Greenberg Classification for Drooling Frequency Never Occasional (not every day) Frequent (every day) Constant (every day and night) Severity Dry Mild (wets only lips) Moderate (wets lips and chin) Severe (wets clothing) Profuse (wets environment: objects, floor, other people) Evaluation Teacher Drool Scale (TDS; Camp-Bruno,Winsberg, Green-Parsons, & Abrams, 1989). 5-point scale, measuring (a) no drooling; (b) infrequent drooling, small amount; (c) occasional drooling, on and off all day; (d) frequent drooling, but not profuse; and (e) constant drooling, always wet. Visual Analogue Scale (Jongerius et al., 2004) Treatment Options - No Treatment - Rehabilitative options - Medical Treatment - Surgical Treatment No Treatment - INSIGNIFICANT PROBLEM - ANTICIPATED IMPROVEMENT - DROOLING LOW PRIORITY - UNCONCERNED CAREGIVER Rehabilitative options - Correct situational factors - Oral motor therapy - Behaviour therapy Rehabilitative options - Correct situational factors - Oral motor therapy - Behaviour therapy Rehabilitative options - Correct situational factors - Oral motor therapy - Behaviour therapy Behaviour therapy - In recent years, there has been a paucity of behavioral studies on drooling- 19 since 1970!!! - The focus has been on medication and surgical interventions. However, medication has only a temporary effect (Jongerius et al., 2004), and surgery does not always totally eliminate drooling (Greensmith et al. 2005). - “ Given their potential effectiveness, behavioral procedures should be reconsidered.” (Van der Burg 2007) Behaviour therapy - The goal is to establish, increase, or decrease specific behavior by systematically manipulating its antecedent stimuli (events preceding the target behavior) and/or consequent (events following the target behavior) stimuli. -There are four main types of treatment procedures: - (a) instruction, prompting, and positive reinforcement; - (b) negative social reinforcement and decelarative procedures; - (c) cueing techniques; -(d) self-management procedures. Surgical Treatment Surgical Treatment - Indications - Failure of medical Rx - Obstructive factors - Profuse drooling with low awareness level - Severe aspiration Macroglossia • Pt with sialorrhea who could touch his forehead with his tongue Tongue reduction Surgical Treatment Procedures designed to redirect the salivary flow: - Relocation of the parotid ducts (Wilkie & Brody 1977) - Submandibular duct relocation - Submandibular duct relocation with sublingual gland excision (SDRSGE) SDRSGE – COMPLICATIONS 10% of patients: - Bleeding - Tongue swelling with airway obstruction - Submandibular abscess - Lingual nerve injury - Aspiration pneumonia Surgical Treatment Procedures designed to decrease the salivary flow: - Tympanic neurectomy - Parotid duct ligation - 4 Duct ligation - Bilateral excision of the submandibular glands +/- ligation of the parotid duct Tympanic Neurectomy - Loss of taste - Recurrence of symptoms within 6 months of surgery Bilateral excisions of the submandibular Glands & ligation of parotid ducts Cincinnati Children’s Hospital, 93 children (Stern 2002) 7 Xerostomia 2 dental caries 1 wound hematoma 1 parotitis Average F/up of 4.2 years: - Significant improvement in drooling in 65% - Cessation of drooling in 21% Pharmacotherapy Pharmacotherapy • Glycopyrrolate (Bachrach 1998) – In a survey of 41 caregivers of children with cerebral palsy • Improvement in drooling in 95% of patients • SIDE_EFFECTS LEAD TO DISCONTINUATION IN 1/3 • Dry mouth, thick secretions, urinary retention, flushing Pharmacotherapy • Glycopyrrolate (Mier 2000) – Placebo-controlled, double-blind, crossover dose-ranging study – 39 children with dev delay & excessive drooling – All children completing the study had a significant improvement with glycopyrrolate when compared to placebo – 20% withdrawal due to adverse effects Pharmacotherapy • Scopolamine patch (Brodtkorb 1988) – Placebo-controlled, double-blind, crossover dose-ranging study – 18 children with dev delay & excessive drooling – Significant reduction in drooling 24 to 72 hours after the patch is applied with drowsiness as the only reported side effect – Other trials less successful (Lewis 1994) Pharmacotherapy • A daily dosage of 3–3.8 mg benztropine could be effective. • An impressive reduction in the mean score for drooling is described with benzhexol hydrochloride (2x2 mg up to 2x3 mg daily). Jongerius PH, van Tiel P, van Limbeek J, Gabreels FJ, Rotteveel JJ. A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Arch Dis Child. 2003 Oct;88(10):911-4. Review. Sialorrhea Agent Dosage Side effect Glycopyrolate Adult: start at .5 mg Dry mouth, thick secretion, orally, one to three urinary retention, flushing, and times daily constipation Children:0.04 mg per Kg per dose orally, q8- 12h Scopolamine (Transderm Apply patch every day Pruritus, urinary retention, Scop) 1.5 mg irritability, blurry vision, glaucoma Botulinum toxin A 10 units in to each Pain at injection site submandibular and parotid gland Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhea: a management challenge. Am Fam Physician. 2004 Jun 1;69(11):2628-34. BOTULINUMBOTULINUM TOXINTOXIN INJECTIONINJECTION FORFOR SIALORRHEASIALORRHEA BOTULINUM TOXIN Normal Neuromuscular Function Arnon et al. JAMA 2001;285(8):1059-1070 Botulinum Toxin Mechanism of Action Arnon et al. JAMA 2001;285(8):1059-1070 BOTOX Injection 60% Excellent response 20% Good response 20 % Poor response 10% no response with high doses Ideal along with oral motor therapy SAFETYSAFETY OFOF BOTULINUMBOTULINUM TOXINTOXIN FORFOR SIALORRHEASIALORRHEA • Recent reports have hit the media involving the reporting of serious side effects as a result of using Botox injections, and these reports were generated by the Ralph Nader-founded consumer advocacy group known as Public Citizen, which tracked 180 reports of problems with Botox to the FDA and found three side effects to be the most serious. • Each of these side effects is briefly described below, but if you have been injured as a result of Botox injections,
Load more

Recommended publications
  • Glossary for Narrative Writing
    Periodontal Assessment and Treatment Planning Gingival description Color: o pink o erythematous o cyanotic o racial pigmentation o metallic pigmentation o uniformity Contour: o recession o clefts o enlarged papillae o cratered papillae o blunted papillae o highly rolled o bulbous o knife-edged o scalloped o stippled Consistency: o firm o edematous o hyperplastic o fibrotic Band of gingiva: o amount o quality o location o treatability Bleeding tendency: o sulcus base, lining o gingival margins Suppuration Sinus tract formation Pocket depths Pseudopockets Frena Pain Other pathology Dental Description Defective restorations: o overhangs o open contacts o poor contours Fractured cusps 1 ww.links2success.biz [email protected] 914-303-6464 Caries Deposits: o Type . plaque . calculus . stain . matera alba o Location . supragingival . subgingival o Severity . mild . moderate . severe Wear facets Percussion sensitivity Tooth vitality Attrition, erosion, abrasion Occlusal plane level Occlusion findings Furcations Mobility Fremitus Radiographic findings Film dates Crown:root ratio Amount of bone loss o horizontal; vertical o localized; generalized Root length and shape Overhangs Bulbous crowns Fenestrations Dehiscences Tooth resorption Retained root tips Impacted teeth Root proximities Tilted teeth Radiolucencies/opacities Etiologic factors Local: o plaque o calculus o overhangs 2 ww.links2success.biz [email protected] 914-303-6464 o orthodontic apparatus o open margins o open contacts o improper
    [Show full text]
  • An Approach to the Patient with a Dry Mouth
    MedicineToday 2014; 15(4): 30-37 PEER REVIEWED FEATURE 2 CPD POINTS An approach to the patient with a dry mouth Key points • The subjective complaint of ELHAM AFLAKI MD; TAHEREH ERFANI MD; NICHOLAS MANOLIOS MB BS(Hons), PhD, MD, FRACP, FRCPA; xerostomia needs to be MARK SCHIFTER FFD, RCSI(Oral Med), FRACDS(Oral Med) differentiated from true salivary hypofunction. Dry mouth is a common and disabling problem. After exclusion of treatable • Salivary hypofunction can significantly reduce quality causes, treatment is symptomatic to prevent the consequences of salivary of life through its adverse hypofunction, such as tooth decay and infection of the oral mucosa. effects on taste, mastication, swallowing, cleansing of the erostomia, or the subjective feeling of neuropathic-induced orofacial dysaesthesia) mouth, killing of microbes a dry mouth, is a common complaint. and psychological and psychiatric disorders, and speech. It is often a consequence of salivary such as anxiety and depression. • Salivary hypofunction is a hypofunction (hyposalivation), in substantive risk factor for X which there is objective evidence of reduced NORMAL SALIVA PRODUCTION dental caries, oral mucosal salivary output or qualitative changes in saliva. Under normal physiological conditions, the disease and infection, Typically, patients complain of oral dryness salivary glands produce 1000 to 1500 mL of particularly oral candidiasis. only when salivary secretion is reduced by more saliva daily as an ultrafiltrate from the circu- • Patients should be than half.1 As saliva has a crucial role in taste lating plasma. Therefore, simple dehydration investigated for contributory perception, mastication, swallowing, cleansing reduces saliva production. The parotid glands and underlying causes, of the mouth, killing of microbes and speech, are the major source of serous saliva (60 to 65% which include drugs and abnormalities in saliva production can signif- of total saliva volume), producing the stimu- rheumatological diseases.
    [Show full text]
  • Diseases of Salivary Glands: Review
    ISSN: 1812–1217 Diseases of Salivary Glands: Review Alhan D Al-Moula Department of Dental Basic Science BDS, MSc (Assist Lect) College of Dentistry, University of Mosul اخلﻻضة امخجوًف امفموي تُئة رطبة، حتخوي ػىل طبلة ركِلة من امسائل ثدغى انوؼاب ثغطي امسطوح ادلاخوَة و متﻷ امفراغات تني ااطَة امفموًة و اﻷس نان. انوؼاب سائل مؼلد، ًنذج من امغدد انوؼاتَة، اذلي ًوؼة دورا" ىاما" يف اﶈافظة ػىل سﻻمة امفم. املرىض اذلٍن ؼًاهون من هلص يف اﻷفراز انوؼايب حكون دلهيم مشبلك يف اﻷلك، امخحدث، و امبوع و ًطبحون غرضة مﻷههتاابت يف اﻷغش َة ااطَة و امنخر املندرش يف اﻷس نان. ًوخد ثﻻثة أزواج من امغدد انوؼاتَة ام ئرُسة – امغدة امنكفِة، امغدة حتت امفكِة، و حتت انوساهَة، موضؼيا ٍكون خارج امخجوًف امفموي، يف حمفظة و ميخد هظاهما املنَوي مَفرغ افرازاهتا. وًوخد أًضا" امؼدًد من امغدد انوؼاتَة امطغرية ، انوساهَة، اتحنكِة، ادلىوزيًة، انوساهَة احلنكِة وما كبل امرخوًة، ٍكون موضؼيا مﻷسفل و مضن امغشاء ااطي، غري حماطة مبحفظة مع هجاز كنَوي كطري. افرازات امغدد انوؼاتَة ام ئرُسة مُست مدشاهبة. امغدة امفكِة ثفرز مؼاب مطيل غين ابﻷمِﻻز، وامغدة حتت امفكِة ثنذج مؼاب غين اباط، أما امغدة حتت انوساهَة ثنذج مؼااب" مزخا". ثبؼا" ميذه اﻷخذﻻفات، انوؼاب املوحود يق امفم ٌشار امَو مكزجي. ح كرَة املزجي انوؼايب مُس ثس َطا" واملادة اﻷضافِة اموػة من لك املفرزات انوؼاتَة، اكمؼدًد من امربوثُنات ثنذلل ثرسػة وثوخطق هبدروكس َل اﻷتُذاًت مﻷس نان و سطوح ااطَة امفموًة. ثبدأ أمراض امغدد انوؼاتَة ػادة تخغريات اندرة يف املفرزات و ام كرتَة، وىذه امخغريات ثؤثر اثهواي" من خﻻل جشلك انووحية اجلرثومِة و املوح، اميت تدورىا ثؤدي اىل خنور مذفش َة وأمراض وس َج دامعة. ىذه اﻷمراض ميكن أن ثطبح شدًدة تؼد املؼاجلة امشؼاغَة ﻷن امؼدًد من احلاﻻت اجليازًة )مثل امسكري، امخوَف اهكُيس( ثؤثر يف اجلراين انوؼايب، و ٌش خيك املرض من حفاف يف امفم.
    [Show full text]
  • Parotid Sialolithiasis and Sialadenitis in a 3-Year-Old Child
    Ahmad Tarmizi et al. Egyptian Pediatric Association Gazette (2020) 68:29 Egyptian Pediatric https://doi.org/10.1186/s43054-020-00041-z Association Gazette CASE REPORT Open Access Parotid sialolithiasis and sialadenitis in a 3- year-old child: a case report and review of the literature Nur Eliana Ahmad Tarmizi1, Suhana Abdul Rahim2, Avatar Singh Mohan Singh2, Lina Ling Chooi2, Ong Fei Ming2 and Lum Sai Guan1* Abstract Background: Salivary gland calculi are common in adults but rare in the paediatric population. It accounts for only 3% of all cases of sialolithiasis. Parotid ductal calculus is rare as compared to submandibular ductal calculus. Case presentation: A 3-year-old boy presented with acute painful right parotid swelling with pus discharge from the Stensen duct. Computed tomography revealed calculus obstructing the parotid duct causing proximal ductal dilatation and parotid gland and masseter muscle oedema. The child was treated with conservative measures, and subsequently the swelling and calculus resolved. Conclusions: Small parotid duct calculus in children may be successfully treated with conservative measures which obviate the need for surgery. We discuss the management of parotid sialolithiasis in children and conduct literature search on the similar topic. Keywords: Sialolithiasis, Sialadenitis, Salivary calculi, Parotid gland, Salivary ducts, Paediatrics Background performing computed tomography (CT) of the neck. Sialolithiasis is an obstructive disorder of salivary ductal The unusual presentation, CT findings and its subse- system caused by formation of stones within the salivary quent management were discussed. gland or its excretory duct [1]. The resulting salivary flow obstruction leads to salivary ectasia, gland dilatation Case presentation and ascending infection [2].
    [Show full text]
  • Paediatric Surgery: a Comprehensive Text for Africa
    CHAPTER 39 Salivary Gland Diseases in Children and Adolescents Sunday Olusegun Ajike Kokila Lakhoo Introduction Table 39.1: Classification of salivary gland diseases in children. Salivary glands are found in and around the oral cavity, and they are Nonneoplastic tumours divided into major and minor salivary glands. The major salivary Congenital/developmental glands are the parotid, submandibular, and sublingual glands; the minor Agenesis/aplasia, hypogenesis/hypoplasia salivary glands are located in the lips, buccal mucosa, palate, and throat. Generally, salivary gland diseases are not common in the paediat- Aberrant/ectopic salivary gland ric population. The classification of salivary gland diseases is very Haemangioma complex because it encompasses different entities; however, precise Lympangioma classification and terminology are necessary for accurate diagnosis Inflammatory and infection. and management. As in adults, diseases of the salivary glands may be Acute sialadentis nonneoplastic or neoplastic (tumours) (Table 39.1). The pattern of inci- dence in the paediatric population differs greatly from that in the adult Mumps, cytomegalovirus, Coxasackie A or B or parainfluenza virus) group. Most salivary gland lesions in children are either inflammatory Human immunodeficiency virus (HIV)-associated salivary glands or vascular in origin. Of the developmental salivary gland diseases, Recurrent parotitis in children (RPC) haemangiomas are the most common. In the African paediatric popula- Autoimmune tion, mumps is the most common in the inflammatory/infection group, Sjogren’s syndrome but in the developed world, only sporadic cases of mumps are now reported, and rhabdomyosarcomas are the most common nonodonto- Cysts genic mesenchymal tumours in children. Ranula mucocele (mucous retention cyst) Neoplastic changes in the paediatric population are very rare Salivary gland dysfunction compared to the inflammatory groups.
    [Show full text]
  • Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency
    Practice parameter Practice parameter for the diagnosis and management of primary immunodeficiency Francisco A. Bonilla, MD, PhD, David A. Khan, MD, Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD, David I. Bernstein, MD, Joann Blessing-Moore, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Chief Editor: Francisco A. Bonilla, MD, PhD Co-Editor: David A. Khan, MD Members of the Joint Task Force on Practice Parameters: David I. Bernstein, MD, Joann Blessing-Moore, MD, David Khan, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Primary Immunodeficiency Workgroup: Chairman: Francisco A. Bonilla, MD, PhD Members: Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD GlaxoSmithKline, Merck, and Aerocrine; has received payment for lectures from Genentech/ These parameters were developed by the Joint Task Force on Practice Parameters, representing Novartis, GlaxoSmithKline, and Merck; and has received research support from Genentech/ the American Academy of Allergy, Asthma & Immunology; the American College of Novartis and Merck.
    [Show full text]
  • Unusual Cancer in Primary Sjögren Syndrome
    Case Report Unusual cancer in primary Sjögren syndrome Wen-Sen Lai MD Feng-Cheng Liu MD PhD Chih-Hung Wang MD PhD Hsin-Chien Chen MD PhD jgren syndrome (SS) is the second most common secondary SS described in the literature to date.3 Here Sautoimmune disease, affecting mainly middle-aged we describe a case of NPC in a patient with primary SS. women. The disease might occur alone (primary SS) or in association with other autoimmune diseases such Case as rheumatoid arthritis (secondary SS). The important A 58-year-old woman with a 2-year history of symp- symptoms of SS, dry mouth (xerostomia) and dry eyes tomatic dry eye and mouth was diagnosed with pri- (keratoconjunctivitis sicca), result from lymphocytic infl- mary SS. Initial general physical examination revealed tration and destruction of the exocrine glands, particu- conjunctival congestion and mucosal atrophy of the larly the salivary and lacrimal glands.1 Patients with tongue with atrophic glossitis. Laboratory serologic SS have an elevated risk of developing malignant neo- analysis showed positive titres for antinuclear anti- plasms, particularly hematologic malignancies, with bodies (1:1280, speckled) and anti–Sjgren syndrome most being non-Hodgkin B-cell lymphoma.2 Other can- antigens A and B (>240 U/mL and 172 U/mL, respec- cers, such as oral cancer, breast cancer, and thymoma, tively). Screening for SS showed decreased salivary might also occur in patients with SS. However, the coex- gland function and globular sialectasis on parotid istence of SS with nasopharyngeal carcinoma (NPC) sialography. Results of a Schirmer test during the oph- has rarely been reported, with only one case involving thalmologic examination were positive for dry eyes, and a labial salivary gland biopsy (Figure 1) revealed focal chronic sialadenitis characterized by intense lymphocytic inflammatory infiltrate (focus score >2; EDITOR’S KEY POINTS >100 lymphocytes/4 mm2 of glandular tissue).
    [Show full text]
  • Classification of Salivary Gland Disorders
    Salivary Gland Diseases and Disorders Dr. Mahmoud E. Khalifa Prof of OMFS Lecture ILOs At the end of this chapter you should be able to: 1. Distinguish the clinical features of infections of the salivary glands from those in other structures 2. Differentiate on clinical grounds between infection, obstruction, benign and malignant neoplasms of the salivary glands 3. Plan and evaluate the results of the investigation of disorders of the salivary glands 4. List the important/relevant information to be elicited from patients with salivary gland disorders 5. Select cases which require referral for a specialist opinion 6. Describe the causes of a dry mouth and be able to distinguish between organic and functional causes. Anatomy Major glands Minor glands 3 pairs Situated mostly 800 to 1000 in the oral cavity Parotid Submandibular The majority atAlso found in the the junction of pharynx, larynx, the hard and soft trachea, and palates sinuses sublingual Functions These glands function to produce saliva, which serves as Lubricant for speech & swallowing Assists taste Immunologic (antibacterial) Digestive Cleansing properties Based on the type of secretion, the salivary glands may be grouped as: (i) Serous, (ii) Mucous and (iii) Mixed. Parotid gland secretion is serous in nature. The sublingual gland secretes mixed, but predominantly mucous. The submandibular gland secretion is also mixed, but is predominantly serous. The minor glands secrete mucous saliva. Parotid Gland The parotid gland is the largest salivary gland, the secretion of which is serous in nature. It is pyramidal in shape; The base located superficial and apex medially The base is triangular in shape its apex is towards the angle of the mandible, the base at the external acoustic meatus The parotid duct (Stenson‘s duct) Emerges at the anterior part of the gland.
    [Show full text]
  • Jemds.Com Original Article
    Jemds.com Original Article MR SIALOGRAPHY AND CONVENTIONAL SIALOGRAPHY IN SALIVARY GLAND AND DUCT PATHOLOGIES: A COMPARATIVE STUDY Amarnath Chellathurai1, Sathyan Gnanasigamani2, Shivashankar Kumaresan3, Suhasini Balasubramaniam4, Kanimozhi Damodarasamy5, Komalavalli Subbiah6, Sivakumar Kannappan7, Balaji Selvaraj8 1Professor and HOD, Department of Radiodiagnosis, Stanley Medical College, Chennai. 2Associate Professor, Department of Radiodiagnosis, Stanley Medical College, Chennai. 3Assistant Professor, Department of Radiodiagnosis, Stanley Medical College, Chennai. 4Associate Professor, Department of Radiodiagnosis, Stanley Medical College, Chennai. 5Junior Resident, Department of Radiodiagnosis, Stanley Medical College, Chennai. 6Assistant Professor, Department of Radiodiagnosis, Stanley Medical College, Chennai. 7Assistant Professor, Department of Radiodiagnosis, Stanley Medical College, Chennai. 8Assistant Professor, Department of Radiodiagnosis, Stanley Medical College, Chennai. ABSTRACT BACKGROUND MR Sialography has become an alternative method for imaging the salivary gland and duct. MRI is a non-invasive technique with advantages of superior tissue discrimination and multiplanar facility. MRI has no radiation hazard as compared to the conventional sialography and CT sialography; 3D CISS sequence gives details of salivary gland ducts and sialoliths. AIM To compare the accuracy of the conventional sialography and MR Sialography in the diagnosis of salivary gland and duct pathologies. MATERIALS AND METHODS A prospective study was
    [Show full text]
  • Chapter 11. Non-Neoplastic Diseases of Salivary Glands
    Surgical pathology of the mouth and jaws R. A. Cawson, J. D. Langdon, J. W. Eveson 11. Non-neoplastic diseases of salivary glands Investigation Investigations will be discussed in relation to specific disorders and those more appropriate to neoplasms are discussed in the following chapter. However, it must be emphasized that chronic inflammatory swellings of the major salivary glands, in particular, sometimes cannot be distinguished from neoplasms clinically. Nevertheless, biopsy of the parotid glands is contraindicated because of the frequency of pleomorphic adenomas which can be seeded into the surrounding tissues to produce multiple recurrences. There are also the risks of damaing branches of the facial nerve or of producing a parotid fistula. For imaging techniques, see Chapters 1 and 12. Developmental disorders Aplasia/agenesis. Complete absence of one or more salivary glands is very rare, but occasionally the parotid glands are absent. Absence of all major salivary glands is even more rare. Duct atresia. This is also rare, but usually affects the submandibular duct in the floor of the mouth. Absence of the duct results in retention cysts of the submandibular and sublingual glands. Salivary gland hypoplasia. This can be a feature of the Melkersson-Rosenthal syndrome. The hypoplasia possibly may be secondary to atrophy of parasympathetic nerves thought to be implicated in this syndrome. Congenital salivary fistulae. These are sometimes seen in association with branchial clefts. Aberrant salivary tissue. This is common in the cervical lymph nodes (where it should not be mistaken for a metastasis) and may be found in the middle ear cleft. Stafne's bone cavity is another example.
    [Show full text]
  • Salivary Gland Disorders and Tumours
    Salivary gland disorders and tumours Sumamry This lesson is one we all tend to avoid because most of them sound the same! Hopefully this lesson will help you with clarification. Introduction to Salivary gland disorders and tumours: List of Salivary gland disorders and tumours Viral sialadenitis (mumps) Bacterial sialadenitis Sialosis (sialadenosis) Sialolithiasis Mucocele Acute Necotising Sialometaplasia Tumours: Pleomorphic adenoma Warthins Tumour Mucoepidermoid carcinoma Adenoid cystic carcinoma Acinic cell carcinoma Low-grade polymorphic adenoma Sjogren's syndrome Xerostomia Sialorrhea ReviseDental.com Key words: Sialosis non-pathogenic, non-neoplastic increase in salivary gland size Sialodenitis ductal infection Sialolithiasis duct obstruction Sialectasis cystic widening of the duct Sialorrhea excessive salivation/drooling (1) Acute Viral Sialadenitis Aetiology and epidemiology Common in the childhood disease Mumps caused by the RNA virus Parmyxovirus Typically affects the parotid gland Spread by droplet spread or direct contact 2-3 week incubation period precedes the clinical symptoms Can cause extrasalivary manifestations such as Orchitis Oophoritis Pancreatitis Clinical features Painful Typically bilateral enlargement of parotid glands Skin over the glands is not affected which distinguishes from bacterial sialodenitis Malaise, fever and headaches Histopathology Accumulation of neutrophils and fluid in the lumen of the ductal structures Diagnosis Made on clinical presentation Management FluidsReviseDental.com and medication for
    [Show full text]
  • Treatments for Ankyloglossia and Ankyloglossia with Concomitant Lip-Tie Comparative Effectiveness Review Number 149
    Comparative Effectiveness Review Number 149 Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie Comparative Effectiveness Review Number 149 Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-2012-00009-I Prepared by: Vanderbilt Evidence-based Practice Center Nashville, TN Investigators: David O. Francis, M.D., M.S. Sivakumar Chinnadurai, M.D., M.P.H. Anna Morad, M.D. Richard A. Epstein, Ph.D., M.P.H. Sahar Kohanim, M.D. Shanthi Krishnaswami, M.B.B.S., M.P.H. Nila A. Sathe, M.A., M.L.I.S. Melissa L. McPheeters, Ph.D., M.P.H. AHRQ Publication No. 15-EHC011-EF May 2015 This report is based on research conducted by the Vanderbilt Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-2012-00009-I). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment.
    [Show full text]